167 related articles for article (PubMed ID: 38333072)
1. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor.
Vives Dilme R; Rivas JG; Fernández Hernández L; De la Parra Sánchez I; Sánchez Del Hoyo R; Galante Romo MI; Redondo González E; Senovilla Pérez JL; Fernández Montarroso L; Moreno Sierra J
Ther Adv Urol; 2024; 16():17562872241229250. PubMed ID: 38333072
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
3. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
4. A risk grouping algorithm for predicting factors of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Micoogullari U; Cakici MC; Kisa E; Canda AE; Kilic FU; Ardicoglu A; Altinova S; Atmaca AF; Akbulut Z; Balbay MD
Int J Clin Pract; 2021 Oct; 75(10):e14495. PubMed ID: 34155724
[TBL] [Abstract][Full Text] [Related]
5. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
7. Prostate-Specific Antigen Density as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margin in Radical Prostatectomy Patients with Prostate-Specific Antigen Levels of Less than 10 ng/ml.
Chang JS; Choi H; Chang YS; Kim JB; Oh MM; Moon du G; Bae JH; Cheon J
Korean J Urol; 2011 Dec; 52(12):809-14. PubMed ID: 22216391
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
Koie T; Mitsuzuka K; Yoneyama T; Narita S; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C; Yoneyama T; Tobisawa Y
Int J Clin Oncol; 2015 Feb; 20(1):176-81. PubMed ID: 24771079
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis.
Bhat KRS; Covas Moschovas M; Sandri M; Noel J; Reddy S; Perera R; Rogers T; Roof S; Patel VR
Eur Urol Focus; 2022 Sep; 8(5):1192-1197. PubMed ID: 34736871
[TBL] [Abstract][Full Text] [Related]
11. Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.
Zugor V; Witt JH; Heidenreich A; Porres D; Labanaris AP
Anticancer Res; 2012 May; 32(5):2091-5. PubMed ID: 22593494
[TBL] [Abstract][Full Text] [Related]
12. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
[TBL] [Abstract][Full Text] [Related]
13. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer.
Kang HW; Jung HD; Lee JY; Kwon JK; Jeh SU; Cho KS; Ham WS; Choi YD
Asian J Androl; 2016; 18(3):480-4. PubMed ID: 26178393
[TBL] [Abstract][Full Text] [Related]
15. Prediction of organ-confined disease after robot-assisted radical prostatectomy in patients with clinically locally-advanced prostate cancer.
Kang HW; Jung HD; Lee JY; Kwon JK; Jeh SU; Cho KS; Ham WS; Choi YD
Asian J Surg; 2019 Jan; 42(1):120-125. PubMed ID: 29274670
[TBL] [Abstract][Full Text] [Related]
16. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
[TBL] [Abstract][Full Text] [Related]
17. Surgical and oncological outcomes in patients with a preoperative PSA value <4 ng/ml undergoing robot-assisted radical prostatectomy.
Zugor V; Labanaris AP; Bauer RM; Witt JH
Anticancer Res; 2012 May; 32(5):2079-83. PubMed ID: 22593492
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.
Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
Eur Urol Focus; 2018 Apr; 4(3):351-359. PubMed ID: 28753802
[TBL] [Abstract][Full Text] [Related]
19. LacdiNAc-Glycosylated Prostate-specific Antigen Density is a Potential Biomarker of Prostate Cancer.
Inoue T; Kaneko T; Muramatsu S; Kimura H; Yoshino T; Goto T; Sawada A; Akamatsu S; Kobayashi T; Yamasaki T; Kaya T; Ogawa O
Clin Genitourin Cancer; 2020 Feb; 18(1):e28-e36. PubMed ID: 31711843
[TBL] [Abstract][Full Text] [Related]
20. Learning curve of minimally invasive radical prostatectomy: Comprehensive evaluation and cumulative summation analysis of oncological outcomes.
Sivaraman A; Sanchez-Salas R; Prapotnich D; Yu K; Olivier F; Secin FP; Barret E; Galiano M; Rozet F; Cathelineau X
Urol Oncol; 2017 Apr; 35(4):149.e1-149.e6. PubMed ID: 28117215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
